Cathepsins Drive Anti-Inflammatory Activity by Regulating Autophagy and Mitochondrial Dynamics in Macrophage Foam Cells.
Cathepsins Drive Anti-Inflammatory Activity by Regulating Autophagy and Mitochondrial Dynamics in Macrophage Foam Cells.
复制标题
DOI:
10.33594/000000157
复制
发表时间:
2019-09
期刊:
影响因子:
--
通讯作者:
Tommy Weiss-Sadan;David Maimoun;D. Oelschlagel;F. Kaschani;Danny Misiak;Hanmant Gaikwad;Y. Ben-Nun;E. Merquiol;Adi Anaki;Darya Tsvirkun;M. Kaiser;P. Michl;I. Gotsman;G. Blum
中科院分区:
文献类型:
--
作者:
Tommy Weiss-Sadan;David Maimoun;D. Oelschlagel;F. Kaschani;Danny Misiak;Hanmant Gaikwad;Y. Ben-Nun;E. Merquiol;Adi Anaki;Darya Tsvirkun;M. Kaiser;P. Michl;I. Gotsman;G. Blum
BACKGROUND/AIMS Atherosclerosis underlies the majority of cardiovascular events, consequent to non-resolving inflammation. Considerable evidence implicates autophagy dysfunction at the core of this inflammatory condition, but the basis of this dysfunction is not fully understood. METHODS Using an in vitro model of lipid-laden macrophages, activity-based probes and high-throughput techniques, we studied the role of the cysteine proteases cathepsins in autophagy. RESULTS We showed that cathepsin activity is suppressed by oxidized lipids and that cathepsin has an indispensable role in the autophagy-lysosomal degradation pathway. Accordingly, loss of cathepsin function resulted in autophagy derangement. Shotgun proteomics confirmed autophagy dysfunction and unveiled a pivotal role of cathepsin L in a putative cathepsin degradation network. At the physiological level, cathepsin inhibition resulted in mitochondrial stress, which translated into impaired oxidative metabolism, excessive production of reactive oxygen species and activation of the cellular stress response, driven by ATF4-CHOP transcription factors. In addition, transcriptomic analysis of these cells uncovered some genetic similarities with the inflammatory macrophage phenotype (a.k.a M1 macrophages) and increased expression of inflammatory cytokines. CONCLUSION Our data highlight the importance of cathepsins for mitochondrial quality control mechanisms and amelioration of vascular inflammation.